Author | Date | Comparator | Study size | Reported characterists | Duration | Outcome Measures |
---|---|---|---|---|---|---|
Boulet et al | 2003 | CIC 400 mcg (mdi) od am Vs. BUD 400 mcg (turbo) od am | 359 | Randomized double blind multicenter | 12 weeks parallel | Lung function FEV1 FVC Symptoms Change in symptoms % symptom free days use of rescue meds |
Ukena et al | 2003 | CIC 400 mcg (mdi) od pm Vs. BUD 400 mcg (turbo) od pm | 399 | Randomized double blind multicenter | 12 weeks parallel | Lung function FEV1 FVC, Timing of onset of action PEF Symptoms Change in symptoms % symptom free days use of rescue meds HPA Suppression Urine cortisol |
Hansel et al | 2003 | CIC 100 mcg (mdi) od am Vs. CIC 400 mcg (mdi) od am Vs. BUD 200 mcg (turbo) bd | 554 | Randomized double blind multicenter | 12 weeks parallel | Lung function FEV1 FVC PEF Symptoms Change in symptoms % symptom free days use of rescue meds HPA Suppression Urine cortisol |
Derom et al | 2001 | CIC 400 mcg od Vs. CIC 800 mcg od Vs. CIC 800 mcg bd Vs. FP 500 mcg bd Vs. FP 1000mcg bd | 25 | Randomized double blind double dummy placebo controlled | 7 days 6 period crossover with at least 3 weeks washout period | Airway responsiveness to AMP PC20 FEV1(doubling doses) HPA Suppression Plasma cortisol Urinary cortisol excretion |